Europe

Jun 01, 2016
Eleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the EU.
Jun 01, 2016
NHS England head Simon Stevens believes the UK's PPRS needs significantly updating.
May 25, 2016
We desperately need new anti-infective drugs to avoid life threatening infections. Let’s make that happen by punishing companies who don’t invest in R&D for these specific drugs.
May 06, 2016
Pharmaceutical Executive
European pharma is bracing itself for EFPIA’s June deadline requiring the disclosure of transfer-of-value transactions make to HCPs.
Apr 04, 2016
Reflector sees both altruism and self-interest in European thinking on neglected diseases.
Mar 21, 2016
NICE's notion to charge the industry for its technology appraisals looks set to become reality, writes Leela Barham.
Mar 10, 2016
Elvis Pacelat asks why the prospect of harmonized content is so challenging, and what can pharma companies learn from other sectors about more optimal, modern ways of working and sharing data?
Mar 06, 2016
Pharmaceutical Executive
A new study spells out the many drug pricing problems in Europe just fine, but fails to address a central access issue.
Feb 25, 2016
As a European politician attacks abuses of the orphan drug scheme, an EU report extols its virtues. Reflector asks: in Europe, does the right hand know what the left hand is doing?
Feb 17, 2016
Following the consultation on the future of England's Cancer Drug Fund, Leela Barham reviews what the stakeholders are thinking.
native1_300x100
lorem ipsum